about
Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.Novel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B.Understanding the interaction of an antitumoral platinum(II) 7-azaindolate complex with proteins and DNA.Dual antitumor and antiangiogenic activity of organoplatinum(II) complexes.New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry.Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes.Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.In vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis.Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.New steroidal 7-azaindole platinum(II) antitumor complexes.Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant.New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.A novel ruthenium(II) arene based intercalator with potent anticancer activity.Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity.Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds.New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA.Geometry matters: inverse cytotoxic relationship for cis/trans-Ru(ii) polypyridyl complexes from cis/trans-[PtCl2(NH3)2]Palladium(II) complexes with pentafluorophenyl ligands: structures, C6F5 fluxionality by 2D-NMR studies and pre-catalysts for the vinyl addition polymerization of norbornene.N1-coordination in palladium(II) and platinum(II) complexes with 9-methylhypoxanthine: crystal structures and theoretical calculations.Synthesis and reactivity of bridging and terminal hydrosulfido palladium and platinum complexes. Crystal structures of [NBu4]2[(Pt(c6F5)2(mu-SH)]2], [Pt(C6F5)2(PPh3)[S(H)AgPPh3]], and [Pt(C6F5)2(PPh3)[S(AuPPh3)2]].Insertion reactions into Pd[bond]O and Pd[bond]N bonds: preparation of alkoxycarbonyl, carbonato, carbamato, thiocarbamate, and thioureide complexes of palladium(II).Insertion reactions of SO2 into Pd-OR bonds: preparation of alkyl sulfito complexes of palladium(II).Condensation reactions of monomeric hydroxo palladium complexes with active methyl and methylene compounds.Pentafluorophenyl imidato palladium(II) complexes: catalysts for Suzuki cross-coupling reactions.Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.DFT Simulation of Structural and Optical Properties of 9-Aminoacridine Half-Sandwich Ru(II), Rh(III), and Ir(III) Antitumoral Complexes and Their Interaction with DNA.Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage.Exploring the Effect of the Polypyridyl Ligands on Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents.Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents.A new C,N-cyclometalated osmium(ii) arene anticancer scaffold with a handle for functionalization and antioxidative propertiesSynthesis of 2-Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid-β Aggregation and Neurotoxicity EvaluationFront Cover: Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides (ChemMedChem 17/2018)Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD PeptidesThe synthesis and structure determination of a novel η6-arenerhodium(III) complex, [(Me2SiC6H5)4Rh2H2], and the synthesis of [(Me2SiC6H5)4Ir2H2]
P50
Q34415646-1979B211-34BA-4BDD-BC2B-59B9497903CEQ34542718-1AED487B-4225-4D1A-A811-982189E79DBCQ35222016-B5A107B6-4FAD-4411-890C-CDCF66854730Q35541623-93FC602E-4215-4F95-A067-E4B39A0C59B2Q38708501-8BA55F8C-8B2A-43D9-AE02-9D187F836BE7Q38712938-4677615F-7BA2-4BF1-B037-3CAE68789606Q38840407-5E674B32-6ED9-4FBE-983B-7142DE02488FQ38895597-87C81C06-B25A-48E1-A62E-61498635F2B6Q39063227-FEEBC420-0659-450F-B0E3-9A3DE08CEEA7Q39068148-CB1CD277-E6A9-49F1-A206-88CB2ABC469DQ39112715-CF0D2C3D-5D6F-402B-AB59-DE7B0751B85AQ39442095-D965057F-0E18-4B27-9643-E5189864841AQ39492383-1F81C813-D431-47D7-94AE-E270CBD22931Q39589450-BBB9F5E5-3566-4A67-A0B2-D9A8C961ED61Q39706663-BDA2362C-7BA4-409C-8C6C-763B7592E3B4Q39831855-78DA215A-D815-4C13-8251-98E002D45BC8Q39930956-537A5739-B8BC-4EB4-BFCD-1DF729BA5DB8Q39966593-4C063093-B4F3-4E1E-B276-1DEC144C0CB6Q39986869-D5EFE868-87DB-4361-B450-323312344EEFQ40249688-E0A7394B-796C-4E74-A219-7A5852F20418Q40364373-AA6F72A1-D966-4CA2-AD12-61A3EAD6903EQ42161331-B47257CA-D1E2-48F1-A793-A04D4498C890Q43114259-052C43D3-7C4F-49D0-BD55-7C54304067F3Q43254340-27F580AD-6823-40CE-A625-410851BAD5B3Q43751621-12018280-4E3B-477A-848E-3C47A49EE5B4Q44454148-6BF5E87B-227F-47C7-BA6D-4E5F4F43CDA8Q44977225-2B3CC2AD-6018-4DAB-B50E-8914B9680B96Q45128290-DEB10DD9-B8DE-4435-8A7E-A4759553C153Q46503194-2745DC7E-239B-4FFA-BB06-85DD4B1D9884Q47784937-867BB1BC-87A6-4B68-9C95-483B354DA7CDQ48210595-F988E9BD-F55D-449A-901A-72A4B240BF9FQ48235153-B029300F-F3AE-4816-BD0A-745264D36F79Q48313390-2ED7277B-2C1F-4E84-B3D2-218446B99FE2Q49711415-C2FFEBDC-91EE-40F0-9803-E2052A912387Q52662227-3D71EABF-4C61-456A-BB4C-598B7E6E3342Q57045059-95750D88-A231-4BE3-8E06-968011ACF70EQ57673622-286C0065-94C7-4F24-AC75-946A55E60224Q57975612-E1613A37-BF09-4A69-94AE-DB2A40E73119Q57975614-A615BCC3-CF5C-409D-84E9-C8D7AE9420BCQ59617658-07B625B6-D1A7-474A-B17D-317B45F6F7BB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
José Ruiz
@ast
José Ruiz
@en
José Ruiz
@es
José Ruiz
@nl
José Ruiz
@sl
type
label
José Ruiz
@ast
José Ruiz
@en
José Ruiz
@es
José Ruiz
@nl
José Ruiz
@sl
prefLabel
José Ruiz
@ast
José Ruiz
@en
José Ruiz
@es
José Ruiz
@nl
José Ruiz
@sl
P1053
B-8271-2008
P106
P21
P31
P3829
P496
0000-0002-0834-337X